Ripple
Ripple is a Salt Lake City-based private medical device company founded in 2004 that designs non-invasive brain-computer interface technology using EEG, MEG, and fMRI integration for neuroscience and neuroprosthetics research applications.
- Company typePrivate
- Founded2004
- HeadquartersSalt Lake City, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Ripple does
Ripple is a Salt Lake City, Utah-based private medical device company founded in 2004 that designs and develops non-invasive neural medical devices for neuroscience, neuroprosthetics, and biotechnology research. The company's core offering centers on non-invasive brain-computer interface (BCI) technology primarily utilizing electroencephalography (EEG) for neural signal detection, with a stated differentiator around ease of use and implementation. Ripple has additionally developed proprietary capability for integrating EEG, magnetoencephalography (MEG), and functional magnetic resonance imaging (fMRI) modalities to enhance the accuracy and precision of neural signal detection, providing a multi-modal research platform unusual for a company of its size.
The company operates with a small team of 11-50 employees and targets the broader non-invasive BCI market, which captured 87.5% of global BCI market revenue in 2023 and is projected to grow at 17.9% CAGR through 2033 to reach USD 10.65 billion. Ripple's technology is positioned for applications spanning healthcare, communication, gaming, and military and defense sectors, with healthcare representing the primary demand vertical at 63.3% of total market demand. Detailed product specifications, pricing models, customer relationships, and revenue figures are not publicly disclosed, and the company's own website (rippleneuro.com) returned only a loader page at the time of source collection.
The company is led by CEO Andrew Wilder. No funding rounds, named partnerships, acquisitions, regulatory milestones, awards, patents, or specific customer accounts were identified in the available source material, representing significant data gaps for investment due diligence.
Ripple firmographics
Firmographics- Name
- Ripple
- Website
- https://rippleneuro.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Ripple is a Salt Lake City-based private medical device company founded in 2004 that designs non-invasive brain-computer interface technology using EEG, MEG, and fMRI integration for neuroscience and neuroprosthetics research applications.
- Ownership category
- akta.pro rank
Ripple industry classification
Industry- Product category
- Neural Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)
- akta.pro secondary industry
- SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG)
Keywords
Where Ripple is headquartered
LocationHeadquarters
- HQ city
- Salt Lake City
- HQ country
- United States
- HQ region
- North America
Markets served
Ripple business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure
Ripple product offering
Product offeringCore offering
Ripple designs and develops non-invasive neural medical devices centered on brain-computer interface (BCI) technology, primarily using EEG for neural signal detection. The devices support neuroscience research, neuroprosthetics development, and biotechnology applications, with proprietary integration of EEG, MEG, and fMRI modalities to enhance accuracy and precision of neural signal capture.
Differentiator
Problem solved
Functional benefit
Products and services
- Non-invasive Brain-Computer Interface (BCI) Medical Devices
Quantifiable outcome
- Non-invasive BCI technologies captured 87.5% revenue share of the global BCI market in 2023
- +2 more outcomes
Companies that use Ripple
Customer profileSegments4 records
Ideal customer profiles2 records
Ripple technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Ripple partnerships and signals
Strategic signalScale indicators7 records
Recent moves3 records
Expansion highlights3 records
Ripple competitors and assessment
Company assessmentDirect peers
- Synchron: Synchron develops a stent-based BCI for paralyzed patients, with FDA breakthrough designation. It is a direct clinical-stage peer advancing BCI technology toward medical use, competing for research and clinical mindshare with Ripple's neural device work.
- Neuralink: Neuralink develops invasive brain-computer interface implants for clinical and consumer applications. It is the highest-profile peer in the BCI category and a benchmark for capital intensity and clinical ambition, though it competes on the invasive side of Ripple's non-invasive focus.
- Emotiv: Emotiv produces non-invasive EEG headsets and software for research, wellness, and consumer applications. It is a direct non-invasive BCI peer, sharing Ripple's EEG-based acquisition approach and overlapping research-customer base.
- Blackrock Neurotech: Blackrock Neurotech builds invasive BCI systems primarily for neuroscience research, closely paralleling Ripple's research- and neuroscience-focused positioning. Both companies sell neural acquisition platforms to research labs.
- Interaxon (Muse): Interaxon produces the Muse EEG brain-sensing headband and accompanying software for meditation, sleep, and consumer wellness. It is a direct non-invasive EEG peer with overlapping neural signal acquisition technology and an adjacent end-customer focus.
Emerging players
- OpenBCI: OpenBCI manufactures open-source EEG and biosensing hardware for researchers, developers, and hobbyists. It is an emerging non-invasive peer competing in the research and academic segment where Ripple also operates.
- Paradromics: Paradromics is building high-data-rate invasive BCI technology aimed at clinical and communication applications. It is an emerging peer advancing neural interface engineering with adjacent goals to Ripple's neuroscience and neuroprosthetics focus.
- Kernel: Kernel develops non-invasive neuroimaging and BCI technology for cognitive performance and clinical research. It is an emerging peer pursuing non-invasive neural signal acquisition in adjacent research and consumer markets.
- Neurable: Neurable builds EEG-based brain-computer interface technology integrated into consumer audio products. It is an emerging non-invasive BCI peer expanding into consumer applications that overlap with parts of Ripple's neural interface scope.
- Neurosity: Neurosity produces consumer-grade EEG devices and a developer platform for brain-computer interface experimentation. It is an emerging peer targeting developers and researchers, partially overlapping with Ripple's research-customer focus.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat2 records
Key risks6 records
Key highlights5 records
Customer concentration
Ripple social profiles
Digital presenceRipple financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ripple leadership team
Management profileNumber of profiles
Profiles1 record
Ripple funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ripple M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ripple
What does Ripple do?
Ripple designs and develops non-invasive neural medical devices centered on brain-computer interface (BCI) technology, primarily using EEG for neural signal detection. The devices support neuroscience research, neuroprosthetics development, and biotechnology applications, with proprietary integration of EEG, MEG, and fMRI modalities to enhance accuracy and precision of neural signal capture.
Is Ripple a public or private company?
Ripple is a private company. It is classified as unknown and is currently operating.
When was Ripple founded?
Ripple was founded in 2004. It employs 11 to 50 people.
Where is Ripple based?
Ripple is headquartered in Salt Lake City, United States, in the North America region.
Who are Ripple's main competitors?
Direct peers on record are Synchron, Neuralink, Emotiv, Blackrock Neurotech and Interaxon (Muse). Emerging players are OpenBCI, Paradromics, Kernel, Neurable and Neurosity.
Does Ripple have an API?
No public API is recorded for Ripple.
What industry is Ripple in?
Ripple's product category is Neural Medical Devices. Its primary akta.pro industry code is HLAHACAE, Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables), with a secondary code of HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML). Its NAICS code is 334510 and its SIC code is 3845.